Abstract
AimWe previously performed the first trio‐based exome study for bipolar disorder and identified 71 de novo mutations. Among these mutations, the only mutation located at the splice donor site was in UNC13B. We focused on and analyzed the functions of the mutation.MethodsIn order to analyze the functional alterations, due to the mutation, we performed a minigene splicing assay.Key resultsWe found that the mutation caused the loss of a wild‐type splicing variant, which was consistent with the computational splice prediction, and that an exon‐skipping variant increased significantly. The exon‐skipping variant also existed in the wild‐type minigene, although it was rare. Hence, we validated the expression of the exon‐skipping variant using total RNAs derived from the human cerebral cortex. We showed the possibility that the exon‐skipping variant was rare, but expressed even in those that do not carry the mutation.ConclusionsBased on our results, we suggest that an abnormal splicing pattern of UNC13B occurred in the patient, which could be related to the pathophysiology of bipolar disorder.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.